Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Ya Watanabe

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Psychiatric Research|May 7, 2015
Biological tests for major depressive disorder that involve leukocyte gene expression assaysShin-Ya Watanabe, Jun-Ichi Iga, Kazuo Ishii, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy SubjectsShin-Ya Watanabe, Jun-Ichi Iga, Shusuke Numata, et al.
Neuropsychiatric Disease and Treatment|March 7, 2017
Gene expression-based biological test for major depressive disorder: an advanced studyShin-Ya Watanabe, Shusuke Numata, Jun-Ichi Iga, et al.
Psychiatry and Clinical Neurosciences|May 24, 2020
Association between serum folate levels and schizophrenia based on sexYukiko Tomioka, Makoto Kinoshita, Hidehiro Umehara, et al.
Journal of Affective Disorders|May 26, 2015
Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese populationShin-ya Watanabe, Jun-ichi Iga, Shusuke Numata, et al.
Scientific Reports|July 9, 2017
Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorderHidehiro Umehara, Shusuke Numata, Shin-Ya Watanabe, et al.
Neuropsychiatric Disease and Treatment|April 20, 2018
Elevated peripheral blood glutamate levels in major depressive disorderMasatoshi Inoshita, Hidehiro Umehara, Shin-Ya Watanabe, et al.
The International Journal of Eating Disorders|October 9, 2015
Risk factors for refeeding hypophosphatemia in Japanese inpatients with anorexia nervosaNaomi Kameoka, Jun-ichi Iga, Mai Tamaru, et al.
Neuroscience Letters|December 15, 2010
Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese populationMasahito Nakataki, Jun-ichi Iga, Shusuke Numata, et al.
Psychiatry Research|November 5, 2016
Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia riskMakoto Kinoshita, Shusuke Numata, Atsushi Tajima, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Psychiatric Research|May 7, 2015
Biological tests for major depressive disorder that involve leukocyte gene expression assaysShin-Ya Watanabe, Jun-Ichi Iga, Kazuo Ishii, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy SubjectsShin-Ya Watanabe, Jun-Ichi Iga, Shusuke Numata, et al.
Neuropsychiatric Disease and Treatment|March 7, 2017
Gene expression-based biological test for major depressive disorder: an advanced studyShin-Ya Watanabe, Shusuke Numata, Jun-Ichi Iga, et al.
Psychiatry and Clinical Neurosciences|May 24, 2020
Association between serum folate levels and schizophrenia based on sexYukiko Tomioka, Makoto Kinoshita, Hidehiro Umehara, et al.
Journal of Affective Disorders|May 26, 2015
Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese populationShin-ya Watanabe, Jun-ichi Iga, Shusuke Numata, et al.
Scientific Reports|July 9, 2017
Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorderHidehiro Umehara, Shusuke Numata, Shin-Ya Watanabe, et al.
Neuropsychiatric Disease and Treatment|April 20, 2018
Elevated peripheral blood glutamate levels in major depressive disorderMasatoshi Inoshita, Hidehiro Umehara, Shin-Ya Watanabe, et al.
The International Journal of Eating Disorders|October 9, 2015
Risk factors for refeeding hypophosphatemia in Japanese inpatients with anorexia nervosaNaomi Kameoka, Jun-ichi Iga, Mai Tamaru, et al.
Neuroscience Letters|December 15, 2010
Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese populationMasahito Nakataki, Jun-ichi Iga, Shusuke Numata, et al.
Psychiatry Research|November 5, 2016
Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia riskMakoto Kinoshita, Shusuke Numata, Atsushi Tajima, et al.
Pageof 2